UnknownNot applicableNCT04291898

Comparison of Devices for Atrial Septal Defects Closure: A Pilot Study

Studying Interatrial communication

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Health Network, Toronto
Principal Investigator
Eric Horlick, MD, M.D
University Health Network, Peter Munk Cardiac Centre
Intervention
AMPLATZER™ Septal Occluder.(device)
Enrollment
60 enrolled
Eligibility
18-110 years · All sexes
Timeline
20222024

Study locations (4)

Collaborators

Montreal Heart Institute · Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec · St. Paul's Hospital, Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04291898 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication

← Back to all trials